A phase 2/3, observer-blind, randomized, controlled study to determine the safety & immunogenicity of Covishield (Covid-19 vaccine) in healthy Indian adults

Accessibility Controls

Principal Investigator

Ms. C. Padmapriyadarsini Director The INCLEN Trust International Delhi

Indian Council of Medical Research (ICMR)

Area of Research

Medical Sciences

Focus Area

Task Force (TF)

Start Date

2020

End Date

2021

Duration

Status

Completed

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls